Detalles de la búsqueda
1.
Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women.
Int J Cancer
; 131(6): 1388-95, 2012 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22120998
2.
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (Part 3 - Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization).
Bioanalysis
; 14(11): 737-793, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35578991
3.
Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection.
J Clin Microbiol
; 49(5): 1899-906, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21346041
4.
Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay.
J Clin Microbiol
; 49(5): 1907-12, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21068278
5.
Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
Int J Cancer
; 127(5): 1151-7, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20039323
6.
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Lancet
; 373(9679): 1949-57, 2009 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-19493565
7.
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
N Engl J Med
; 356(19): 1928-43, 2007 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17494926
8.
Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays.
J Clin Microbiol
; 47(7): 2106-13, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19420164
9.
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.
Hum Vaccin
; 5(10): 696-704, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19855170
10.
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women.
Int J Cancer
; 122(6): 1311-8, 2008 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18000825
11.
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.
Lancet
; 369(9574): 1693-702, 2007 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-17512854
12.
HPV genotypes in CIN 2-3 lesions and cervical cancer: a population-based study.
Int J Cancer
; 121(12): 2682-7, 2007 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17724723
13.
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
BMJ
; 341: c3493, 2010 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20647284
14.
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
J Natl Cancer Inst
; 102(5): 325-39, 2010 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20139221
15.
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.
J Infect Dis
; 199(7): 936-44, 2009 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19236277
16.
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
J Infect Dis
; 199(7): 926-35, 2009 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19236279
17.
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.
Cancer Prev Res (Phila)
; 2(10): 868-78, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19789295
18.
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
Vaccine
; 26(52): 6844-51, 2008 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-18930097
19.
Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas.
J Med Virol
; 78(1): 117-24, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16299730
20.
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18.
Vaccine
; 24(27-28): 5571-83, 2006 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-16753240